Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 210598

YUPELRI (REVEFENACIN)
175MCG/3ML
Marketing Status: Prescription
Active Ingredient: REVEFENACIN
Proprietary Name: YUPELRI
Dosage Form; Route of Administration: SOLUTION; INHALATION
Strength: 175MCG/3ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N210598
Product Number: 001
Approval Date: Nov 9, 2018
Applicant Holder Full Name: MYLAN IRELAND LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English